[ Pharmaceutical Sciences Asia - ONLINE ]
Print ISSN 2586-8195 E-ISSN 2586-8470
[ Journal Abbreviation: Pharm.Sci.Asia ]
Mahidol University Journal of Pharmaceutical Sciences
  FORMER NAME   "Mahidol University Journal of Pharmaceutical Sciences" Published Since 1974

 
Abstracts

DOI: 10.29090/psa.2020.03.019.0007Pharm Sci Asia ; 47(3), 274-278
 

Antihypertensive drugs and new-onset diabetes in Thai Isan patients

Pornpun Chalermrum1, Phisitt Vejakama2, Nonglek Kunawaradisai3, Sawaeng Watcharathanakij3*

1 Department of Pharmacy, Phusing Hospital, Sisaket, Thailand
2 Department of Internal Medicine, Sunpasithiprasong Hospital, Ubon Ratachathani, Thailand
3 Department of Pharmacy Practice, Faculty of Pharmaceutical Science, Ubon Ratchathani University, Ubon Ratchathani, Thailand


Diabetes is a major global public health problem worldwide caused by many factors including genetics and medication. Antihypertensive drugs had been reported to be associated with new-onset diabetes (NOD) in many countries, but not in Thai patients with hypertension. The purpose of this study was to investigate the association between antihypertensive drugs and NOD among Thai Isan patients. This retrospective cohort study obtained data from electronic medical records from community hospitals in Ubon Ratchathani from January 1, 2007 through December 31, 2015. Newly diagnosed hypertensive patients aged ≥ 20 years who received ACEI-based, thiazide-based and combined regimen were identified by ICD 10 code (I10 – I15) and were followed up for 6 years or diagnosed with NOD (E10 – E14). Propensity score was used as a covariate to control for confounding by indication bias due to non-randomly selection process during routine clinical treatment of hypertensive patients. Kaplan-Meier analysis and multivariate cox regression with propensity score adjustment were used to investigate the incidence and the risk of NOD. Of 3,689 newly diagnosed hypertension patients enrolled, 396 (10.73%) patients developed NOD during follow-up period. NOD incidence were 11.06 (95%CI, 9.19 – 13.27), 14.17 (95%CI, 12.48 – 16.05), and 14.17 (95%CI, 11.53 – 17.35) in ACEI-based, thiazide-based and combined regimen users respectively. After adjusting for confounding by indication, the Hazard Ratios were 1.540 (95%CI, 0.963 – 2.463) for thiazide-based regimen and 1.341 (95%CI, 0.769–2.338) for combined regimen compared to ACEI-based regimen. In conclusion, thiazide-based and combined regimen were not associated with NOD compared with ACEI-based regimen in Thai Isan patients.


Keyword:

Antihypertensive drugs; New-onset diabetes; Thai Isan patients




Download full paper (PDF File size: 943.88 KB.)





Vol.47
No.3
July - September 2020

See other volume

 


Vol.47
No.2
April - June 2020

See other volume

 


Vol.47
No.1
January - March 2020

See other volume

 
 
 

Home
Aims and Scope
Editorial Board
Publication Ethics
Instruction to Authors
Announcement
All Volumes & Issues
Submit Online
Contact us
   
Search
   
Faculty of Pharmacy Mahidol University
Mahidol University
Member's menu

You're now loging on with following account:
Guest (unknown)

Please Sign in or Register



    Copyright © 2017
    Faculty of Pharmacy, Mahidol University, THAILAND